CHI Releases Pre-Registrant List for its 12th Annual Structure-Based Drug Design Event

May 3, 2012 - PRLog -- CHI/Bio-IT World's releases a partial delegate list of those attending its 12th annual Structure-Based Drug Design: Predicting Biological and Kinetic Profiles from Structure conference:

Actelion Pharmaceuticals Ltd   
Sr. Scientist

Albany College of Pharmacy & Health Sciences   
Prof & Chair

Amgen Inc   
Sr Scientist

ARIAD Pharmaceuticals Inc   
Dir Structural & Computational Chemistry

Array BioPharma Inc   
Director, Early Drug Discovery

Astex Pharmaceuticals
VP Discovery Technology

Benedictine College   
Associate Professor, Chemistry & Biochemistry

Boehringer Ingelheim Pharma   
Principal Scientist, Medicinal Chemistry

Boehringer Ingelheim Pharma GmbH & CO KG   
Research Consultant, Lead
Identification

Boston University
Professor, Chemistry

Boston University   
Asst Professor, Bioinformatics

Brigham & Womens Hospital   
Asst Professor, Medicine

Brigham & Womens Hospital   
Assistant Director, Drug Discovery

Chemical Computing Group Inc.   
Principal Scientist, Scientific Support

CoMentis   
Principal Scientist, Medicinal Chemistry

CoMentis   
Director, Crystallography

Cubist Pharmaceuticals Inc.   
Research Assoc

Cubist Pharmaceuticals Inc.
Scientist

DE Shaw Research   
Research Scientist Analyst

Eli Lilly & Co.   
Sr Research Scientist

Eli Lilly & Co.   
Director

EMD Serono Research Institute   
Sr Scientist II, Molecular Interactions & Biophysics

Emerald Biostructures   
Sr Research Scientist

Emils Molecular Design LLC   
CSO

EPFL Lausanne   
Master Student

EpiZyme Inc.   
Scientist, Biochemistry & Molecular Pharmacology

EpiZyme Inc.   
Executive Vice President & CSO

EpiZyme Inc   
Assoc Director, Protein & Structural Sciences

FORMA Therapeutics Inc   
VP Medicinal & Computational Chemistry

Fujitsu Ltd
Researcher, In Silico Drug Discovery Research

Georgia Institute of Technology   
Graduate Research Asst

Heptares Therapeutics Ltd   
Sr Computational Chemist

ImClone Systems a wholly owned subsidiary of Eli Lilly & Co   
Sr Scientist, Computational Discovery

Institute Of Organic Chemistry & Biochemistry   
PostDoc Fellow, Computational Chemistry

iRND3   
CEO

Life Chemicals Inc.   
Vice President, Marketing & Sales

Lilly Research Labs   
Distinguished Lilly Research Scholar

Merck   
Biophysics Team Lead

Mitsubishi Tanabe Pharma Corp   
Sr Research Scientist

National Institute for Research on Reproductive Health   
Scientist, Biomedical Informatics

NIH NIDDK   
Scientist, Biological Modeling

Novartis Institutes for BioMedical Research   
Dir Computational Chemistry

Novartis Institutes for BioMedical Research   
Investigator I, Developmental & Molecular Pathways

Novartis Institutes for Biomedical Research   
Assoc Dir CADD Cheminformatics

Novartis Institutes for BioMedical Research Inc.   
Head

Ohio State University   
Assoc Prof

ONO Pharmaceutical Co Ltd   
Researcher

Pfizer Global R&D   
Principal Scientist, Discovery Chemistry

Pfizer Global R&D Groton Labs   
Principal Scientist, Neuroscience

Protagonist Pty Ltd   
Scienstist, Drug Discovery

QuantumBio Inc.   
GM

Receptos Inc.   
Dir Structural Biology

RIKEN Yokohama Institute   
Research Scientist

Schrodinger Inc.   
VP Applications Science

Scripps Research Institute   
Director, Scientific Computing

Shiv Nadar University   
Prof

St Jude Childrens Research Hospital   
PostDoc

Synta Pharmaceuticals Corp.   
Sr Scientist

Targacept Inc.   
Sr Computational Scientist

Thomas Jefferson University
Asst Professor, Pharmaceutical Sciences

Topharman Shanghai Co Ltd   
Dir Medicinal Chemistry

Topharman Shanghai Co Ltd   
Business Development Manager

UCB Pharma SA   
Principal Scientist, CADD

University of Barcelona   
ICREA Research Prof

Univ of California, San Diego   
Professor, Molecular Biology

Univ of Florida Gainesville   
Professor of Chemistry, Quantum Theory Project

Univ of Jordan   
Assoc Prof Molecular Biology

Univ of Kansas Lawrence   
Assoc Prof

Univ of Miami   
Research Assistant Professor, Molecular & Cellular Pharmacology

Univ of Michigan   
Research Scientist, Medicinal Chemistry

Univ of Michigan   
Graduate Student, Medicinal Chemistry

Univ of Minnesota Twin Cities   
Research Associate, Medicinal Chemistry

Univ Of North Carolina Charlotte   
Associate Professor, Physics & Optical Science

Univ of North Carolina Charlotte   
Professor, Bioinformatics & Genomics

Univ of the Sciences in Philadelphia   
Graduate Student

Univ of Tokyo   
Project Assoc Prof

Univ Of Zurich   
Scientist, Biochemistry

Univ Of Zurich   
Scientist, Biochemistry

Vanderbilt University   
Research Asst Prof

Vanderbilt University   
Research Asst Prof

Vernalis Ltd   
Dir Structural Sciences

Vertex Pharmaceuticals Inc.   
Research Scientist

Vipergen   
CEO

Advance registration discounts end on May 4, 2012. To view the agenda and to register, visit http://www.healthtech.com/sbd.

To inquire about sponsoring and/or exhibiting, contact Jon Stroup, 781-972-5483, jstroup@healthtech.com.

Writers and editors are encouraged to attend. To request a press pass, contact Tracey Fielding at tfielding@healthtech.com

About Cambridge Healthtech Institute (www.chicorporate.com)

CHI is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and CHI’s Media Group, which includes news websites and e-newsletters including Bio-IT World and eCliniqua. Founded in 1992, CHI strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments.

Contact:

James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com